Evidence map›Paper›PMID 37954588›Full record

ArticleFrontiers in immunology2023

Glycosylation of bacterial antigens changes epitope patterns.

Karolin Kern, Nicolas Delaroque, Anders Boysen, Marcus Puder, Ralph Wendt, Andreas Kölsch, Eva Ehrentreich-Förster, Kristian Stærk, Thomas Emil Andersen, Karin Andersen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Karolin KernLigand Development Unit, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Nicolas DelaroqueLigand Development Unit, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Anders BoysenGlyProVac ApS, Odense, Denmark.
Marcus PuderEpitopic, Leipzig, Germany.
Ralph WendtDepartment of Nephrology, St. Georg Hospital Leipzig, Leipzig, Germany.
Andreas KölschMicroDiagnostics Unit, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Eva Ehrentreich-FörsterMolekulare und Zelluläre Bioanalytik Unit, Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Golm, Germany.
Kristian StærkDepartment of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Thomas Emil AndersenDepartment of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Karin AndersenDepartment of Urology, Odense University Hospital, Odense, Denmark.
Lars LundDepartment of Urology, Odense University Hospital, Odense, Denmark.
Michael SzardeningsLigand Development Unit, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Fraunhofer Institute for Cell Therapy and Immunology · DEOdense University Hospital · DKUniversity of Southern Denmark · DKKlinikum St. Georg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Unlike glycosylation of proteins expressed in mammalian systems, bacterial glycosylation is often neglected in the development of recombinant vaccines. Methods: Here, we compared the effects of glycosylation of YghJ, an Results: The study identifies differences in the immune response for (non)-glycosylated antigens in rabbits and pigs and compares them to a large group of patients with UTI, which have been diagnosed as positive for various bacterial pathogens. We identified glycosylation-specific peptide epitopes, a large immunological similarity between different UTI pathogens, and a broad peptide epitope pattern in patients and animals, which could result in a variable response in patients upon vaccination. Discussion: This epitope analysis indicates that the vaccination of rabbits and pigs raises antibodies that translate well into the human immune system. This study underlines the importance of glycosylation in bacterial vaccines and provides detailed immune diagnostic methods to understand individual immune responses to vaccines.

Indexed as

Escherichia coli ProteinsUrinary Tract InfectionsAnimalsAntigens, BacterialEpitopesEscherichia coliGlycosylationHumansMammalsMetalloproteasesPeptidesRabbitsSwineAntigens, BacterialEpitopesEscherichia coli ProteinsMetalloproteasesPeptidesYghJ protein, E coliACFDepitopeEscherichia coliprotein glycosylationSSLEuropathogenicvaccine developmentYghJ

Identifiers

PMID37954588
PMCPMC10637626
OpenAlexW4387956859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.